NCT06809829

Brief Summary

The goal of this clinical trial is to Evaluate the effect of Doxycycline nanoparticles along with gelatin sponge in immediate implant cases in esthetic zone. The main question it aims to answer is: Does the application of doxycycline nanoparticles with gelatin sponge improve the clinical and radiographic outcomes of immediate implant cases in esthetic zone? Researchers will compare eight patients undergoing immediate implant placement with the buccal gap filled with doxycycline loaded gelatin nanoparticles along with gelatin sponge (group A) with eight patients undergoing immediate implant placement with the buccal gap filled with doxycycline along with gelatin sponge (group B). to see if the doxycycline loaded nanoparticles will improve the clinical and radiographic outcomes of the immediate implant . Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
9mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Feb 2025Feb 2027

First Submitted

Initial submission to the registry

January 30, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

February 5, 2025

Status Verified

January 1, 2025

Enrollment Period

1.4 years

First QC Date

January 30, 2025

Last Update Submit

February 4, 2025

Conditions

Keywords

Immediate Implant PlacementNanoparticlesDoxycyclineGelatin Sponge

Outcome Measures

Primary Outcomes (1)

  • Marginal (crestal) bone loss (MBL).

    Radiographic examination of the patients will be done firstly pre-operative then just after the surgical procedures as a base point and at six months follow-up period post-operative by using CBCT (carestream 9600). On Demand3D program will be used for image reconstruction and analysis. For the calculation of marginal (crestal) bone loss (MBL), the implant will be used as a reference by adjusting the cross-sectional long axis in the center of the implant and bisecting it. A line will be drawn parallel to the implant, starting at the crest of the bony cortical plate of bone and ending at the apical level of the implant; height will be recorded in millimeters immediately and 6 months postoperative. The same process will be repeated from the palatal direction.

    after surgery and 6 months after surgery

Secondary Outcomes (4)

  • Pink Esthetic Score

    before the surgery, 3 months and 6 months after the surgery

  • Peri-Implant Periodontal Probing depth (PPD):

    3 months and 6 months after the surgery

  • Peri-implant vertical bone level.

    after surgery and 6 months after surgery

  • Implant stability

    at the time of surgery, 3 months and 6 months post surgery

Study Arms (2)

immediate implant placement with doxycycline loaded gelatin nano particles and gelatin sponge

EXPERIMENTAL
Procedure: Immediate Implant Placement

Immediate Implant Placement with Doxycyline and Gelatin Sponge

ACTIVE COMPARATOR
Procedure: Immediate Implant Placement

Interventions

Eight patients undergoing immediate implant placement with the buccal gap filled with doxycycline loaded gelatin nanoparticles along with gelatin sponge (group A) Eight patients undergoing immediate implant placement with the buccal gap filled with doxycycline along with gelatin sponge (group B)

Immediate Implant Placement with Doxycyline and Gelatin Spongeimmediate implant placement with doxycycline loaded gelatin nano particles and gelatin sponge

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The presence of non-restorable single-rooted maxillary centrals, canines or premolars.
  • Sufficient bone volume.
  • Good oral hygiene.
  • The remaining space between the socket and the fixture equals or more than 2mm at the coronal third of the socket.
  • Sufficient bone width (≥ 1 mm) in the buccal plate of the remaining bone to place an implant confirmed by cone beam computer tomography (CBCT).

You may not qualify if:

  • Insufficient bone volume.
  • Active infection.
  • Patients on chemotherapy or radiotherapy.
  • Patients who have systemic disorders {uncontrolled diabetes mellitus, autoimmune disease, …etc},
  • Pregnant patients,
  • Patients with bone diseases
  • Presence of periapical pathology affecting the neighbouring teeth.
  • Smokers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry kafrelsheikh university

Kafrelsheikh, Kafrelsheikh, 12345, Egypt

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
demonstrator of Department of Periodontology, Oral Diagnosis and Oral Radiology at Faculty of Dentistry, Kafrelsheikh university

Study Record Dates

First Submitted

January 30, 2025

First Posted

February 5, 2025

Study Start

February 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

February 5, 2025

Record last verified: 2025-01

Locations